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Abstract 
The cytosolic glutathione S-transferases comprise a pivotal enzyme system protecting 
the cell from electrophilic compounds. It plays a major role in the detoxication of the 
primary and dihydrodiol epoxides of polycyclic aromatic hydrocarbons (PAHs), so 
that modulation of this enzyme system by PAHs will impact on their carcinogenic 
activity. The potential of six, structurally diverse PAHs, namely benzo[a]pyrene, 
fluoranthene, benzo[b]fluoranthene, dibenzo[a,l]pyrene, dibenzo[a,h]anthracene and 
1-methhylphenanthrene, to modulate hepatic glutathione S-transferase activity was 
investigated in human precision-cut slices and compared to rat slices, a species 
frequently used in long-term carcinogenicity studies; changes were monitored at the 
activity, using three different substrates, protein and mRNA levels. When activity was 
monitored using the α-class selective 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole, 
benzo[b]fluoranthene was the only PAH that caused an increase in activity, which was 
accompanied by a rise in the Ya immunoreacting band. In rat slices, in addition to 
benzo[b]fluoranthene, benzo[a]pyrene and dibenzoa[a,h]anthracene also enhanced 
activity, being paralleled with increased levels of the Ya immunoreacting band. In the 
rat, all PAHs elevated mRNA levels. In both human and rat liver slices, only 
benzo[b]fluoranthene enhanced activity when 1-chloro-2,4-dinitrobenzene served as 
substrate. To investigate tissue differences, similar studies were undertaken in 
precision-cut rat lung slices, incubated with PAHs under identical conditions, using 1-
chloro-2,4-dinitrobenzene, as this was the only substrate for which activity could be 
detected; none of the PAHs studied stimulated activity. It is concluded that some 
PAHs have the potential to induce glutathione S-transferase activity in human liver 
tissue, and that species and tissue differences exist in the induction of this enzyme 
system in the rat. However, the extent of induction of glutathione S-transferase 
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activity is very modest compared with the effect these compounds have on CYP1 
expression, the family responsible for their bioactivation, and it is unlikely to 
compensate for the enhanced production of reactive intermediates. 
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Introduction 
The majority of chemicals manifest their toxicity and carcinogenicity through 
metabolically-generated reactive intermediates. Most frequently these are the products 
of oxidation, usually catalysed by the cytochromes P450 (1). Being electrophiles, 
these reactive intermediates can readily interact with vital cellular macromolecules 
leading to toxicity and carcinogenicity. Such reactive intermediates include epoxides, 
which have been implicated in the carcinogenicity of numerous chemicals, including 
polycyclic aromatic hydrocarbons (2), mycotoxins such as aflatoxin B1 (3), and 
halogenated aliphatic compounds such as vinyl chloride (4).  
 The principal protective mechanism of living organisms against epoxides is to 
deactivate them by metabolically converting them to inactive, readily excretable 
metabolites. One of the most important enzyme systems catalysing the detoxication of 
epoxides are the cytosolic glutathione S-transferases, a superfamily that exists as a 
number of isoenzymes, and is widely distributed into various tissues but predominates 
in the liver (5). These enzymes catalyse the conjugation of epoxides and other reactive 
intermediates with glutathione, a nucleophilic tripeptide present in cellular cytosol. In 
fact, in the search for naturally-occurring chemopreventive agents, induction of the 
glutathione S-transferase system is considered a very desirable characteristic (6). 
Many putative chemopreventive phytochemicals act, at least partly, by stimulating the 
detoxification of reactive intermediates through conjugation with glutathione (7,8).  
 Although a number of studies have shown that glutathione S-transferase is an 
inducible enzyme in cell lines derived from human tissues, to our knowledge the 
regulation of this enzyme in human tissues, such as the liver has not been 
investigated. The advent of precision-cut slices, which can be generated automatically 
by a slicing apparatus and can be maintained viable in culture, makes it possible to 
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undertake such studies (9,10). Since the glutathione S-transferases play a pivotal role 
in the bioactivation of polycyclic aromatic hydrocarbons (PAHs), a major class of 
environmental carcinogens, by detoxicating both the primary- and the dihydrodiol-
epoxides, up-regulation of this enzyme system was investigated in precision-cut 
human liver slices following incubation with six structurally-diverse PAHs 
characterised with different carcinogenic activity. As the rat is the most commonly 
used species in carcinogenicity studies, with the findings extrapolated to humans, it 
was of interest and relevance to compare the response in rat liver slices with that 
observed in human slices exposed to the same PAHs under the same conditions. 
Finally, since the lung is a principal target organ in PAH-induced carcinogenesis, the 
up-regulation of the glutathione S-transferase system by the six PAHs was evaluated 
in rat lung slices and compared to the liver. 
 
Materials and methods 
Benzo[a]pyrene [B(a)P], fluoranthene [F], benzo[b]fluoranthene [B(b)F], 
dibenzo[a,h]anthracene [D(a,h)A], 1-chloro-2,4-dinitrobenzene (CDNB) and 1,2-
dichloro-4-nitrobenzene (DCNB) (Sigma-Aldrich Co. Ltd., Poole, Dorset, UK), 
dibenzo[a,l]pyrene [D(a,l)] and 1-methylphenanthrene [(1-MP)] (LGC Promochem, 
Middlesex, UK), 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (Fluka, Buchs SG, 
Switzerland), Qiagen RNeasy Mini kits (Crawley, West Sussex, UK), AbsoluteTM QPCR 
Mix (Abgene, Epsom, Surrey, UK),   and Earle’s balanced salt solution (EBSS), foetal 
calf serum, gentamycin and RPMI with L-glutamine culture media (Gibco-BRL Life 
Technologies, Paisley, Scotland) were all purchased. Twelve-well plates were 
obtained from Bibby Sterilin (Helena Biosciences, Sunderland, UK). Antibody to the 
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Ya subunit of the α-family of glutathione S-transferases was obtained from Oxford 
Biomedical Research (Oxford, MI, USA). 
 
Preparation and incubation of precision-cut tissue slices 
Liver sections from two human cadaveric livers that could not be used for 
transplantation purposes were obtained from the UK Human Tissue Bank (The 
Innovation Centre, Oxford Street, Leicester, UK). The particulars of the donors and 
metabolic viability of slices have already been described (11).  Male Wistar albino 
rats (200g) were obtained from B&K Universal Ltd (Hull, East Yorkshire, UK). The 
animals were housed at 22 ± 2 °C, 30-40 % relative humidity in an alternating 12-hr 
light:dark cycle with light onset at 07.00 hr. Rats were killed by cervical dislocation, 
and liver was immediately excised.  
Rat and human liver slices (250 μm) were prepared from 8mm cylindrical 
cores using a Krumdieck tissue slicer (Alabama Research and Development 
Corporation, Munsford, AL, USA) as previously described (10). The multiwell plate 
procedure, using 12-well culture plates, was used to culture the slices. The culture 
medium was essentially that described by Lake et al. (12) and comprised RPMI 1640 
Glutamax II containing foetal calf serum (5%), L-methionine (0.5 mM), insulin (1 
μM), gentamycin (50 μg/mL) and hydrocortisone 21-hemisuccinate (0.1 mM). One 
slice was placed in each well, in 1.5 ml of culture medium. Slices were incubated 
under sterile conditions on a reciprocating plate shaker housed in a humidified 
incubator, at a temperature of 37 ºC and under an atmosphere of 95 % air/5% CO2. 
The slices were initially pre-incubated for 30 min in order to slough off any dead cells 
due to the slicing process. For the production of lung slices, animals were killed by an 
overdose of sodium pentobarbital, and lungs were perfused intratracheally with 
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agarose (0.75% v/w) at 37 °C. Agar was allowed to solidify, and lung slices (600 μm) 
were prepared from cylindrical cores (8 mm) as described for the liver (13). A pre-
incubation of 60 min was carried out. Three different slice pools, comprising 4-10 
slices, were used per time point. Both liver and lung slices were incubated with the 
various PAHs for 24 h, in accordance with our previous studies (10,11). 
 
Enzyme assays 
Following incubation, slices were removed from the medium, homogenised, and 
cytosolic fractions were prepared by differential centrifugation. Cytosolic glutathione 
S-transferase activity (14) was monitored using three accepting substrates whereas 
protein concentration was determined using bovine serum albumin as standard (15). 
The incubation conditions used and the range of concentrations of the various PAHs 
were based on our previous optimisation studies (10). The three substrates used to 
monitor glutathione S-transferase activity in the various tissues were 7-chloro-4-
nitrobenzo-2-oxa-1,3-diazole whose conjugation  is selectively catalysed by the α-
class of transferases; CDNB which is a non-specific substrate, whose conjugation 
with glutathione is catalysed by a number of glutathione S-transferases isoenzymes, 
including the α-, μ- and π-classes, and DCNB which is particularly catalysed 
primarily by the μ-class (5,16). 
Finally, in order to determine changes in enzyme protein expression, hepatic 
cytosolic proteins were resolved by electrophoresis and incubated with the primary 
antibody  (antibody to the rat Ya subunit of the α-family raised in goat) and the 
corresponding peroxidase-linked anti-goat IgG. Immunoblots were quantitated by 
densitometry using the GeneTool software (Syngene Corporation, Cambridge, UK).  
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Transcript level measurement 
Two slices were used for total RNA extraction, and for each sample triplicate 
extractions were carried out. RNA was extracted using the Qiagen RNeasy Mini kit 
and was quantified using a Nanodrop spectrophotometer. Total RNA was treated with 
RNase-free DNase to remove genomic contamination. Reverse transcription was 
primed with random hexamers and carried out by Superscript II according to the 
manufacturer’s instructions. To ensure that DNase-treated samples were free from 
genomic contamination, an RT- control was carried out for every RNA sample. cDNA 
generated from 50ng was amplified using AbsoluteTM QPCR Mix with 400 nM 
primers and 100 nM fluorogenic probe in a total reaction volume of 25μl. Q-PCR 
reactions were run on the ABI7000 SDS instrument and quantitation was carried out 
using the ABI proprietary software against a standard curve generated from rat 
genomic DNA. 
For the quantitative reverse transcription-polymerase chain reaction, the 
primer and TAMRA/FAM dual labelled probe (10) were designed using the Primer 
Express software (Applied Biosystems, CA,USA) and purchased from MWG 
(Ebersberg), Germany. The  5′-primer  ( CCATGGCCAAGACTACCTTGTAG ),  3′-
primer (AGGCTGGCATCAAACTCTTCA) and  probe 
(CCGGGTAGACATCCACCTGCTGGAAC)  were designed to amplify sequences 
within a single exon, so that genomic DNA could be used as a standard. 
Induction potency for individual PAHs was calculated from the linear part of 
the concentration-activity graph plot, using the Prism software (version 4.03, 
GraphPad), and values are expressed as fold-increase/μmole.  
Statistical evaluation was carried out using the Student’s t-test. 
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Results 
When glutathione S-transferase activity was monitored using 7-chloro-4-nitrobenzo-2-
oxa-1,3-diazole as the substrate, benzo[a]pyrene (80%), and to a lesser extent 
dibenzo[a,h]anthracene (40%) and benzo[b]fluoranthene (15%), were the only PAHs 
that caused a statistically significant increase in activity in rat liver slices; maxima 
were reached at a PAH concentration of about 5-10 μM (Figure 1). When CDNB or 
DCNB served as the accepting substrates, only benzo[b]fluoranthene caused a weak 
(15%), but statistically significant rise in glutathione S-transferase activity (Figures 2 
and 3). Benzo[a]pyrene, benzo[b]fluoranthene and dibenzo[a,h]anthracene, but not the 
other PAHs, decreased glutathione S-transferase activity at the highest concentrations 
of 50-100 μM, whatever the substrate used (Figures 1-3). Immunoblot analysis 
revealed a single immunoreacting protein; quantification by densitometry showed a 
clear rise in protein levels in the liver microsomes from  benzo[b]fluoranthene-
,benzo[a]pyrene- and, to a lesser extent, dibenzo[a,h]anthracene-treated rat liver slices 
(Figure 4). All PAHs studied caused an increase in glutathione S-transferase mRNA 
levels, with benzo[b]fluoranthene being clearly the most potent (Figure 5); potency of 
induction by individual PAHs is shown in Table I. 
 When glutathione S-transferase was assayed using either DCNB or CDNB as 
substrates, activity in the two human liver samples was similar to that seen in the rat; 
in the case of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole, however, activity was higher 
in the two human livers. When human liver slices were incubated with the various 
PAHs under identical conditions to the rat slices and 7-chloro-4-nitrobenzo-2-oxa-1,3-
diazole was employed as the substrate, benzo[b]fluoranthene was the only PAH that 
caused a statistically significant rise in activity (25%) (Figure 6); a similar picture 
emerged when CDNB was utilised as the substrate (Figure 7). None of the PAHs 
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studied modulated glutathione S-transferase activity significantly when DCNB was 
the substrate used to monitor activity (Figure 8). None of the compounds impaired 
glutathione S-transferase activity at 50 μM, the highest concentration employed, 
whatever the substrate (Figures 6-8), which contrasts with the rat studies. Antibodies 
to the Ya protein recognised a single immunoreacting band, which was elevated only 
in the slices exposed to benzo[b]fluoranthene (Figure 9). 
 No activity was detectable in rat lung slices incubated for 24 hours, when 
DCNB or 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole were used. However, activity was 
detectable in the presence of CDNB but it was only about 10% of that observed in the 
liver; none of the PAHs used elevated glutathione S-transferase activity (Figure 10). 
 
Discussion 
The studies with rat liver slices indicate that glutathione S-transferase is an 
inducible enzyme when exposed to PAHs, but the extent of induction is low when 
compared to enzyme systems such as the CYP1 family of cytochromes P450 (11). 
Moreover, not all PAHs stimulated activity at the concentrations studied. Of the six 
PAHs investigated, benzo[b]fluoranthene, benzo[a]pyrene and dibenzo[a,h]anthracene 
stimulated glutathione S-transferase activity, when assessed using as substrate 7-
chloro-4-nitrobenzo-2-oxa-1,3-diazole. The fact that the effects were absent or less 
pronounced when glutathione S-transferase activity was monitored with CDNB or 
DCNB would imply that PAHs may display selectivity towards the α-class. In 
concordance with the present findings, when liver slices were exposed to the same 
series of PAHs and changes in gene expression were assessed using oligonucleotide 
microarrays respectively, an increase in the gene expression of the α1 isozyme was 
noted only in the case of benzo[a]pyrene, benzo[b]fluoranthene and 
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dibenzo[a,h]anthracene (17). In addition to increases in transcript expression, we 
demonstrate that these are paralleled by an increase in protein expression indicating 
that higher enzyme availability is likely to be responsible for the observed rise in 
activity. This is consistent with previous work that 3-methylcholanthrene, another 
PAH, increases selectively the expression of the Ya subunit (18,19). At the activity 
level, employing DCNB as substrate, 3-methylcholanthrene elevated activity in mice, 
but failed to do so in Sprague-Dawley rats (19,20); a modest increase was only noted 
when activity was monitored using the non-specific CDNB as substrate (21). 
Moreover, in the present studies an increase in the mRNA levels of the α-class of 
glutathione S-transferases elicited by these three PAHs raises the possibility of 
transcriptional activation. It should be pointed out that, as the Q-PCR technology 
measures transcript pool size, it is not possible to rule out mRNA stabilisation as a 
possible mechanism. Induction by planar compounds of the α-class of   the 
glutathione S-transferase isoenzymes is believed to be regulated by the aryl 
hydrocarbon receptor, a transcriptional factor residing in the cellular cytosol (22). 
Indeed, of the six PAHs employed in the present study, benzo[b]fluoranthene, 
benzo[a]pyrene and dibenzo[a,h]anthracene are the best ligands for this receptor and 
the most potent inducers of CYP1, the up-regulation of which is also regulated by the 
aryl hydrocarbon receptor (11). As PAHs lose their planarity, the Ah affinity 
diminishes, and a good correlation is evident (R = 0.74, Figure 11) between rise in 
mRNA levels and the calculated area/depth2 (11), an index of planarity (23). 
Dibenzo[a,l]pyrene also caused an increase in the glutathione S-transferases mRNA 
levels, despite being a poor ligand to the aryl hydrocarbon receptor, but this was 
translated to neither increased protein expression nor activity. Such a discrepancy 
between mRNA levels and enzyme expression and activity has been reported also for 
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other enzymes involved in xenobiotic metabolism (11). It has been proposed that a 
threshold exists that has to be exceeded in order for mRNA to be translated, so that 
activation of the gene at the mRNA level does not always lead to elevated protein 
levels (24). However, the fact the mRNA levels were monitored in the complete slice 
but activity/protein in the isolated microsomes could have contributed to this lack of 
correlation as translation products of mRNA could have been missed. Furthermore, as 
mRNA levels were determined only at a single time point, differences in temporal 
response may be partly responsible. 
 The fact that both liver donors were smokers (11), we believe has not 
impacted on the outcome of these studies as the glutathione S-transferases were 
poorly or not induced by the PAH 3-methylcholantrene in the liver or other tissues in 
rodents, even following intake of high doses administered intraperitoneally (20,21). In 
human liver slices, glutathione S-transferase activity determined using CDNB was 
markedly higher than when DCNB served as substrate, in agreement with previous 
studies conducted in human liver (25). When human liver slices were exposed to the 
same series of PAHs, under identical incubation conditions, a significant increase in 
activity was observed only in the presence of benzo[b]fluoranthene and, similar to rat 
slices, when glutathione S-transferase was monitored using either 7-chloro-4-
nitrobenzo-2-oxa-1,3-diazole or CDNB as substrates. As this rise in activity was 
accompanied by elevated levels of immunoreactive Ya, it may be inferred that 
increased enzyme levels are responsible for this increase, rather than activation of pre-
existing enzyme. No statistically significant increase was observed with any of the 
other PAHs studied. These observations raise the possibility that the α-class of 
glutathione S-transferases is more inducible in rat than in human liver; however, 
analysis of a larger number of human liver samples would be required for such a 
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conclusion to be firmly reached. It is noteworthy to point out that, of the six PAHs 
studied, benzo[b]fluoranthene is the most avid ligand for the aryl hydrocarbon 
receptor (11). 
Glutathione S-transferase activity in the rat lung is generally only about 10-
15% of the hepatic activity (26,27).  In the present studies, in contrast to the liver, no 
glutathione S-transferase activity was detectable in the lungs when 7-chloro-4-
nitrobenzo-2-oxa-1,3-diazole was utilised as substrate, presumably as the α-class of 
transferases is not expressed in the lung (5).  Similarly, no activity was detectable in 
the lung slices when the μ-class probe DCNB was used. Although activity using 
DCNB as substrate in the lung has been reported, this was only about 10% of the 
hepatic activity, and this may explain the lack of activity observed herein (26-28). It 
should be emphasised that as cytochrome P450 and phase II conjugation enzyme 
activities decline following a 24-hour incubation, activity may drop below the 
detection limit (29).  Glutathione S-transferase activity was detectable only when 
CDNB was used. CDNB is a non-specific substrate, the conjugation of which with 
glutathione is catalysed by a number of glutathione S-transferases isoenzymes, 
including the μ- and π-classes (16), which are expressed in the lung (4). It is also 
pertinent to point out that the rate of conjugation of CDNB in rat lung is far higher 
when compared with DCNB (27,28). The lack of inducibility of the glutathione S-
transferase enzyme system by PAHs in the lung may impact adversely as to the 
sensitivity of this organ to the carcinogenicity of these compounds, especially in view 
of the high inducibility of CYP1A1/1B1 (11), the enzymes responsible for their 
bioactivation in this tissue. As the dihydrodiol epoxides, the principal genotoxic 
metabolites, are not substrates of the epoxide hydrolase, their detoxification is 
effected primarily by the glutathione S-transferases (30). 
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 In the studies with rat liver slices, glutathione S-transferase activity dropped 
below control levels at the highest concentrations (50–100 μM) of 
benzo[b]fluoranthene, dibenzo[a,h]anthracene and benzo[a]pyrene. This is unlikely to 
be due to decreased slice viability as it was not observed at the protein level. 
Moreover, leakage of lactic dehydrogenase into the culture medium, an index of slice 
viability, was not influenced by incubation with the various PAHs, at least up to 
concentrations of 100 μM (results not shown). Most likely the drop in activity 
represents enhanced generation of metabolically-formed electrophiles, such as 
epoxides and quinones, which, following saturation of deactivating pathways, are now 
available to bind to the enzymes impairing their activity. Indeed, the three PAHs that 
displayed this behaviour are the most potent inducers of the CYP1 family (11), which 
is responsible for the bioactivation of PAHs, among the six compounds studied. The 
fact that this behaviour was not evident when human slices were used may reflect the 
lower inducibility of the CYP1 family in human liver (11). Similarly, this drop in 
activity at high PAH concentrations was not seen in the lung, since in this organ, even 
after PAH-mediated induction, CYP1 activity, as exemplified by the O-deethylation 
of ethoxyresorufin, was much lower in lung compared with liver slices (11). 
 In summary, the present study has established that: (a) the α-class of 
glutathione S-transferases is modestly inducible by PAHs, but  the extent depends on 
the nature of the PAH involved; (b) up-regulation of this enzyme by PAHs may 
involve transcriptional activation; (c) suggests that induction potential is related to the 
activation of the aryl hydrocarbon receptor; (d) glutathione S-transferase activity is 
not inducible in the rat lung when assessed using CDNB, and (e) for the first time, to 
our knowledge, it is demonstrated that glutathione S-transferase activity is inducible 
in human liver tissue. Although it appears that human hepatic glutathione S-
 15
transferases are less sensitive to induction by PAHs compared with the rat, for such a 
conclusion to be firmly reached, studies should be extended to include more human 
liver samples and a larger series of PAHs. 
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Table I: Induction potency of glutathione S-transferase mRNA levels by PAHs in 
precision-cut rat liver slices 
 
Induction potency values of the PAHs were calculated from the linear part of the 
concentration-activity graph plot, using the Prism software version 4.03 (GraphPad 
Inc, CA). 
 
PAH Glutathione S-transferase mRNA levels
(fold increase/μmol of PAH) 
Benzo[b]fluoranthene 4.35 
Dibenzo[a,l]pyrene 3.17 
Benzo[a]pyrene 2.48 
Dibenzo[a,h]anthracene 2.11 
Fluoranthene 1.24 
1-methylphenanthrene 0.59 
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Legends to figures 
Figure 1: Concentration-dependent induction of glutathione S-transferase (GST) 
activity, monitored using 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole, by PAHs in 
precision-cut rat liver slices. 
 
Precision-cut rat liver slices were incubated in the absence and presence of the various 
PAHs, dissolved in DMSO, at a range of concentrations (0-100 μM) for 24 hours. At 
the end of the incubation period, slices were removed from the media, cytosol 
prepared and glutathione S-transferase activity determined using 7-chloro-4-
nitrobenzo-2-oxa-1,3-diazole as substrate. Results are expressed as mean ± SD of 
triplicate pools of slices. 
* P<0.05; ** P<0.01; *** P<0.001 
Benzo[a]pyrene data from Pushparajah et al (10). 
 
Figure 2: Concentration-dependent induction of glutathione S-transferase (GST) 
activity, monitored using CDNB, by PAHs in precision-cut rat liver slices. 
 
Precision-cut rat liver slices were incubated in the absence and presence of the various 
PAHs, dissolved in DMSO, at a range of concentrations (0-100 μM) for 24 hours. At 
the end of the incubation period, slices were removed from the media, cytosol 
prepared and glutathione S-transferase activity determined using CDNB as substrate. 
Results are expressed as mean ± SD of triplicate pools of slices. 
* P<0.05 
Figure 3: Concentration-dependent induction of glutathione S-transferase (GST) 
activity, monitored using DCNB, by PAHs in precision-cut rat liver slices. 
 
Precision-cut rat liver slices were incubated in the absence and presence of the various 
PAHs, dissolved in DMSO, at a range of concentrations (0-100 μM) for 24 hours. At 
the end of the incubation period, slices were removed from the media, cytosol 
prepared and glutathione S-transferase activity determined using DCNB as substrate. 
Results are expressed as mean ± SD of triplicate pools of slices. 
* P<0.05; ** P<0.01 
 
Figure 4: Concentration-dependent induction of glutathione S-transferase 
protein levels by PAHs in precision-cut rat liver slices 
 
Precision-cut rat liver slices were incubated in the absence and presence of PAHs (0-
100 μM) for 24 hours. At the end of this period, slices were removed from the media 
and cytosolic proteins were resolved by SDS-PAGE before being transferred 
electrophoretically to nitrocellulose paper. Immunoblot was carried out using anti-rat 
Ya subunit, followed by peroxidase-labelled anti-rabbit IgG; all lanes were loaded 
with 5 μg of protein.  
Benzo[a]pyrene data from Pushparajah et al (10). 
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Figure 5: Concentration-dependent changes in glutathione S-transferase mRNA 
levels in precision-cut rat liver slices incubated with PAHs. 
 
Precision-cut rat liver slices were incubated in the absence and presence of the various 
PAHs, dissolved in DMSO, at a range of concentrations for 24 hours. At the end of 
the incubation period, slices were removed from the media and total RNA extracted. 
Glutathione S-transferase mRNA levels were determined by quantitative RT-PCR 
(TaqMan). Changes are shown as fold-increases compared to control slices incubated 
with DMSO only. Results are expressed as mean ± SD where n=4. 
P<0.05; ** P<0.01; *** P<0.001 
Benzo[a]pyrene data from Pushparajah et al (10). 
 
Figure 6: Concentration-dependent induction of glutathione S-transferase (GST) 
activity, monitored using 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole, by PAHs in 
precision-cut human liver slices. 
 
Precision-cut human liver slices were incubated in the absence and presence of the 
various PAHs, dissolved in DMSO, at a range of concentrations (0-50 μM) for 24 
hours. At the end of the incubation period, slices were removed from the media, 
cytosol prepared and glutathione S-transferase activity determined using 7-chloro-4-
nitrobenzo-2-oxa-1,3-diazole as substrate. Results are expressed as mean ± SD of 
triplicate pools of slices. 
* P<0.05 
 
Figure 7: Concentration-dependent induction of glutathione S-transferase (GST) 
activity, monitored using CDNB, by PAHs in precision-cut human liver slices. 
 
Precision-cut human liver slices were incubated in the absence and presence of the 
various PAHs, dissolved in DMSO, at a range of concentrations (0-50 μM) for 24 
hours. At the end of the incubation period, slices were removed from the media, 
cytosol prepared and glutathione S-transferase activity determined using CDNB as 
substrate. Results are expressed as mean ± SD of triplicate pools of slices. 
* P<0.05 
 
Figure 8: Concentration-dependent induction of glutathione S-transferase (GST) 
activity, monitored using DCNB, by PAHs in precision-cut human liver slices. 
 
Precision-cut human liver slices were incubated in the absence and presence of the 
various PAHs, dissolved in DMSO, at a range of concentrations (0-50 μM) for 24 
hours. At the end of the incubation period, slices were removed from the media, 
cytosol prepared and glutathione S-transferase activity determined using DCNB as 
substrate. Results are expressed as mean ± SD of triplicate pools of slices. 
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Figure 9: Concentration-dependent induction of glutathione S-transferase 
protein levels by benzo[b]fluoranthene in precision-cut human liver slices 
 
Precision-cut human liver slices were incubated in the absence and presence of 
benzo[b]fluoranthene (0-50 μM) for 24 hours. At the end of this period, slices were 
removed from the media and cytosolic proteins were resolved by SDS-PAGE before 
being transferred electrophoretically to nitrocellulose paper. Immunoblot was carried 
out using anti-rat Ya subunit, followed by peroxidase-labelled anti-rabbit IgG; all 
lanes were loaded with 5 μg of protein. Figures above the immunoblot represent 
percentage values compared with control (DMSO-treated) slices which were set at 
100%.  
 
Figure 10: Concentration-dependent induction of glutathione S-transferase 
(GST) activity, monitored using CDNB, by PAHs in precision-cut rat lung slices. 
 
Precision-cut rat lung slices were incubated in the absence and presence of the various 
PAHs, dissolved in DMSO, at a range of concentrations (0-5 μM) for 24 hours. At the 
end of the incubation period, slices were removed from the media, cytosol prepared 
and glutathione S-transferase activity determined using CDNB as substrate. Results 
are expressed as mean ± SD of triplicate pools of slices. 
 
Figure 11: Correlation between glutathione S-transferase mRNA-induction 
potency of PAHs and molecular size. 
 
Area/depth2 (a/d2) values from Pushparajah et al (11), determined from the 
dimensions (length, width and depth) of each molecule).  All structural calculations 
were conducted on the Sybyl 7.0 (Tripos Associates, St. Louis, MO) molecular 
modelling suite of programs operating under Linux. 
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